ReachMD
Be part of the knowledge.™Episodes 16-30 of 31
Case Study: How Do We Optimize Treatment Adherence with ARIs in Localized Prostate Cancer?
MinuteCE®Case Study: How Do We Optimize Treatment Adherence with ARIs in Localized Prostate Cancer?
Expert Panel: What Is the Future of Early Intensification in Localized Prostate Cancer?
MinuteCE®Expert Panel: What Is the Future of Early Intensification in Localized Prostate Cancer?
Treatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
CME/CETreatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
Optimizing the Use of Immunotherapy in the First-Line Maintenance Setting for Metastatic Urothelial Carcinoma
CME/CEOptimizing the Use of Immunotherapy in the First-Line Maintenance Setting for Metastatic Urothelial Carcinoma
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
CME/CE Broadcast ReplayUnderstanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
CME/CECurrent and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
